메뉴 건너뛰기




Volumn 41, Issue 1, 1999, Pages 104-107

Treatment of refractory Evans' syndrome with cyclosporine and prednisone

Author keywords

Cyclosporine; Evans' syndrome; Prednisone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

EID: 0033040508     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01004.x     Document Type: Article
Times cited : (17)

References (10)
  • 1
    • 0023754297 scopus 로고
    • Evans' syndrome in childhood: Pathophysiology, clinical course and treatment
    • Wang WC. Evans' syndrome in childhood: pathophysiology, clinical course and treatment. Am. J. Pediatr. Hematol. Oncol. 1988; 10: 330-8.
    • (1988) Am. J. Pediatr. Hematol. Oncol. , vol.10 , pp. 330-338
    • Wang, W.C.1
  • 2
    • 0342308483 scopus 로고
    • Autoimmune hemolytic anemia: Immune pancytopenia
    • Nathan DG, Oski FA, eds., WB Saunders Company, Mexico
    • Schreiber AD, Gill FM, Manno CS. Autoimmune hemolytic anemia: Immune pancytopenia. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood, 4th edn., Vol. 1 WB Saunders Company, Mexico, 1993; 506-7.
    • (1993) Hematology of Infancy and Childhood, 4th Edn. , vol.1 , pp. 506-507
    • Schreiber, A.D.1    Gill, F.M.2    Manno, C.S.3
  • 3
    • 0028217271 scopus 로고
    • Treatment of refractory Evans' syndrome with alternate-day cyclosporine and prednisone
    • Rackoff WR, Manno CS. Treatment of refractory Evans' syndrome with alternate-day cyclosporine and prednisone. Am. J. Pediatr. Hematol. Oncol. 1994; 16: 156-9.
    • (1994) Am. J. Pediatr. Hematol. Oncol. , vol.16 , pp. 156-159
    • Rackoff, W.R.1    Manno, C.S.2
  • 4
    • 0028863026 scopus 로고
    • Evans' syndrome. Results of a pilot study utilizing a multiagent treatment protocol
    • Scaradavou A, Bussell J. Evans' syndrome. Results of a pilot study utilizing a multiagent treatment protocol. Am. J. Pediatr. Hematol. Oncol. 1995; 17: 290-5.
    • (1995) Am. J. Pediatr. Hematol. Oncol. , vol.17 , pp. 290-295
    • Scaradavou, A.1    Bussell, J.2
  • 6
    • 0023711705 scopus 로고
    • Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease
    • Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988; 72: 555-61.
    • (1988) Blood , vol.72 , pp. 555-561
    • Sullivan, K.M.1    Witherspoon, R.P.2    Storb, R.3
  • 7
    • 0025010784 scopus 로고
    • Control of steroid-resistant autoimmune haemolytic anaemia by cyclosporine
    • Hershko C, Sonnenblick M, Ashkenazi J. Control of steroid-resistant autoimmune haemolytic anaemia by cyclosporine. Br. J. Haematol. 1990; 76: 436-7.
    • (1990) Br. J. Haematol. , vol.76 , pp. 436-437
    • Hershko, C.1    Sonnenblick, M.2    Ashkenazi, J.3
  • 8
    • 0026357016 scopus 로고
    • Cyclosporine in steroid resistant auto-immune haemolytic anaemia
    • Dündar S, Özdemir O, Özcebe O. Cyclosporine in steroid resistant auto-immune haemolytic anaemia. Acta Haematol. 1991; 86: 200-2.
    • (1991) Acta Haematol. , vol.86 , pp. 200-202
    • Dündar, S.1    Özdemir, O.2    Özcebe, O.3
  • 9
    • 0026694617 scopus 로고
    • Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
    • Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N. Eng. J. Med. 1992; 326: 1654-60.
    • (1992) N. Eng. J. Med. , vol.326 , pp. 1654-1660
    • Feutren, G.1    Mihatsch, M.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.